A. Boiko

P.182 Metabolic syndrome in patients with schizophrenia and the PTPN5 gene encoding the striatal-enriched protein tyrosine phosphatase

E. Kornetova, I. Pozhidaev, S. Ivanova, 2020, European Neuropsychopharmacology.

Polymorphic variants of xenobiotic metabolism genes and body mass index in schizophrenia patients receiving antipsychotic therapy

E. Kornetova, I. Pozhidaev, A. Boiko, 2019, V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.

P.876 The effect of atypical antipsychotic therapy on hormonal and biochemical parameters in patients with schizophrenia

E. Kornetova, S. Ivanova, A. Semke, 2019, European Neuropsychopharmacology.

Apolipoprotein serum levels related to metabolic side effects in patients with schizophrenia

E. Kornetova, A. Loonen, S. Ivanova, 2018, European Neuropsychopharmacology.

P.374 Cortisol and DHEAS related to metabolic side effects in patients with schizophrenia

E. Kornetova, A. Loonen, S. Ivanova, 2019, European Neuropsychopharmacology.

Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.

M. Sudomoina, O. Favorova, A. Boiko, 2000, Journal of neurovirology.

P.513 Metabolic syndrome in schizophrenia and polymorphic variants of CYP1A2 and GSTP1 genes

E. Kornetova, I. Pozhidaev, S. Ivanova, 2020, European Neuropsychopharmacology.